2022-06-21-世界卫生组织-ACT_Accelerator_Facilitation_Council_Therapeutics_and_Diagnostics_Working_Group_-_Terms_of_reference_2页_130kb

22 June 2022: The ACT Accelerator Facilitation Council has established a Working Group on COVID-19 therapeutics (Tx) and diagnostics (Dx) focused on equitable access. The primary objective is to assess barriers like production, demand, and affordability and provide recommendations. Key functions include increasing political dialogue, addressing policy and legal obstacles, and enhancing transparency. Membership includes countries like South Africa, UK, and others, plus invited organizations. The group operates until September 2022, submitting its report by mid-2022.